The promotion, development, coordination and provision of services related to scientific activities, basic research, clinical research, experimentation, development and production, on its own behalf or on behalf of third parties, of diagnostics involving genetic engineering for pharmaceutical use, of intermediate or finished products intended for the pharmaceutical, biotechnology, chemical and cosmetic industries; the research, development and marketing of new connection devices for ultrafiltration and/or dialysis techniques; the research, development and marketing of new hemofiltration devices for the treatment of cardiac dysfunctions; the research, development and marketing of hypertonic solutions for the ultrafiltration treatment of cardiac dysfunctions; the research, development and marketing of hypertonic solutions for the treatment of pathologies characterized by hyperhydration; the exploitation of industrial property rights, registered and unregistered, acquired by the company in the above-mentioned sectors, both originally and derivatively and/or by virtue of licensing agreements, both active and passive; the national and international registration, extension, acquisition and transfer to third parties of patents and/or industrial property rights related to the activity mentioned above; the production, processing, packaging and distribution of special medicines for human and veterinary use, galenic, chemical, biological and diagnostic products, medical-surgical devices and sanitary articles, medicinal plants and their derivatives, bioelectronic and analytical equipment, scientific and technical instrumentation; the production, processing, packaging and distribution of dietary and food products, cosmetic products, aromatic plants, perfumes and their derivatives; the editing, printing and distribution of scientific publications, editorial activity, including audiovisual media, related to the company's activity, excluding daily newspapers and the sale of training and information services. The company may also provide scientific and technical consulting services to group companies or third parties, facilitate the exchange of information and materials between research units, also in the context of collaboration with other third-party entities, research organizations, and public and private research institutes, centers and laboratories operating in the sector. The company, both in Switzerland and abroad, may, provided that it is deemed instrumental to the above-mentioned purpose or necessary for its achievement: take over the management, operation, liquidation of other companies or enterprises with the same social purpose; carry out all industrial, commercial, financial, movable and immovable operations; take direct or indirect interests or participations in other companies or enterprises with a similar, related or connected purpose, as well as provide guarantees, sureties and guarantees, both real and personal, also in favor of third parties, without limitation, provided that it is in the social interest. The particular enumeration does not limit the company's activity in any way, which must be referred to the broader social purpose. The company also has the possibility of carrying out all other real estate, movable, commercial and financial activities deemed useful for achieving the social purpose, including the granting of real and personal guarantees in favor of third parties.
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubKnowledge
Once Cuoralia Therapeutics Sagl has claimed this profile, we'll publish editorial articles and case studies here together.
Get startedWe're preparing industry comparisons that rank Cuoralia Therapeutics Sagl by reviews, experience and specialisations.